Regulatory Affairs: The IND, NDA, and Post-Marketing

Attend this live, virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs and NDAs, and the importance of regulatory strategy.

返回 Agenda

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part Two

Session Chair(s)

Drusilla Scott, PHD, RAC

Vice President, Regulatory Affairs

Sobi, Inc., United States

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part Two

Regulatory Affairs: The IND, NDA, and Post-Marketing

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part Two

Session Chair(s)

Drusilla Scott, PHD, RAC

获得信息并保持参与